Lysophosphatidic acid and bFGF control different modes in proliferating myoblasts.
Open Access
- 1 January 1996
- journal article
- research article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 132 (1) , 181-193
- https://doi.org/10.1083/jcb.132.1.181
Abstract
Myogenic cells provide excellent in vitro models for studying the cell growth and differentiation. In this study we report that lysophosphatidic acid (LPA), a bioactive phospholipid contained in serum, stimulates the growth and inhibits the differentiation of mouse C2C12 myoblast cells, in a distinct manner from basic fibroblast growth factor (bFGF) whose mitotic and anti-differentiation actions have been well investigated. These actions of LPA were both blocked by pertussis toxin, suggesting the involvement of Gi class of G proteins, whereas bFGF acts through receptor tyrosine kinases. Detailed analysis revealed that LPA and bFGF act differently in regulating the myogenic basic helix-loop-helix (bHLH) proteins, the key players in myogenic differentiation process. LPA stimulates the proliferation of undifferentiated myoblasts allowing the continued expression of MyoD, but in contrast, bFGF does so with the MyoD expression suppressed at the mRNA level. Both compounds maintain the myf-5 expression, and suppress the myogenin expression. In addition, while LPA did not inhibit cell-cell contact-induced differentiation, bFGF strongly inhibited this process. Furthermore, LPA and bFGF act cooperatively in their mitogenic and anti-differentiation abilities. These findings indicate that LPA and bFGF differently stimulate intracellular signaling pathways, resulting in proliferating myoblasts each bearing a distinct expression pattern of myogenic bHLH proteins and distinct differentiation potentials in response to cell-cell contact, and illustrate the biological significance of Gi-mediated and tyrosine kinase-mediated signals.Keywords
This publication has 70 references indexed in Scilit:
- Myogenin gene disruption results in perinatal lethality because of severe muscle defectNature, 1993
- Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin geneNature, 1993
- Temporal and quantitative analysis of myogenic regulatory and growth factor gene expression in the developing mouse embryoDevelopmental Biology, 1992
- Metabolic conversion of the biologically active phospholipid, lysophosphatidic acid, in fibroblastsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Growth factors, signaling pathways, and the regulation of proliferation and differentiation in BC3H1 muscle cells. II. Two signaling pathways distinguished by pertussis toxin and a potential role for the ras oncogene.The Journal of cell biology, 1989
- Growth factors, signaling pathways, and the regulation of proliferation and differentiation in BC3H1 muscle cells. I. A pertussis toxin-sensitive pathway is involved.The Journal of cell biology, 1989
- c-myc Oncogene expression inhibits the initiation of myogenic differentiationExperimental Cell Research, 1987
- Control of myogenic differentiation by fibroblast growth factor is mediated by position in the G1 phase of the cell cycle.The Journal of cell biology, 1985
- Cytoplasmic activation of human nuclear genes in stable heterocaryonsCell, 1983
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959